Marc Schegerin - Jan 14, 2022 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
CFO and COO
Signature
/s/ Robert Farrell as attorney-in-fact for Marc Schegerin, M.D.
Stock symbol
MORF
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 06:11 PM
Previous filing
Nov 3, 2021
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Award $0 +85.6K $0.00 85.6K Jan 14, 2022 Common Stock 85.6K $44.75 Direct F1
transaction MORF Restricted Stock Units (RSU) Award $0 +18.8K $0.00 18.8K Jan 14, 2022 Common Stock 18.8K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.